Innate immunomodulation to trypanosomatid parasite infections

Experimental Parasitology

Volumn 167, Issue , 2016, Pages 67-75

  Dos Santos, A L A ^a,b   Carvalho Kelly, L F ^a,b   Dick, C F ^a,b   Meyer Fernandes, J R ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem   (Brazil)

Author keywords

Innate immune cells; PAMPs; TLRs; Trypanosomatid

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CRYOPYRIN; GAMMA INTERFERON; GLYCOINOSITOLPHOSPHOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE SYNTHASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EXTRACELLULAR TRAP; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LEISHMANIA; MACROPHAGE; NEUTROPHIL; NONHUMAN; PARASITE VIRULENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; TRYPANOSOMATID INFECTION; ANIMAL; IMMUNOLOGY; LEISHMANIASIS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; LEISHMANIA; LEISHMANIASIS; MACROPHAGES; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; TOLL-LIKE RECEPTORS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 84973663362     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2016.05.005     Document Type: Review

References (107)

1. Abel L.C., Ferreira L.R., Cunha Navarro I., et al. Induction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN-γ and CD40-CD40L interactions. Mediat. Inflamm. 2014, 2014, Article ID 345659, 7.
2. Abi Abdallah D.S., Denkers E.Y. Neutrophils cast extracellular traps in response to protozoan parasites. Front. Immunol. 2012, (3):382.
3. Alba Soto C.D., Mirkin G.A., Solana M.E. Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner. Infect. Immun. 2003, 71(3):1194-1199.
4. Aldridge J.R., Vogel I.A. Macrophage biology and their activation by protozoan-derived glycosylphosphatidylinositol anchors and hemozoin. J. Parasitol. 2014, 100(6):737-742.
5. Aliberti J., Viola J.P., Vieira-de-Abreu A., et al. Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J. Immunol. 2003, 170(11):5349-5353.
6. Amin D.N., Vodnala S.K., Masocha W., et al. Distinct Toll-like receptor signals regulate cerebral parasite load and interferon α/β and tumor necrosis factor α-dependent T-cell infiltration in the brains of Trypanosoma brucei-infected mice. J. Infect. Dis. 2012, 205(2):320-332.
7. Bafica A., Santiago H.C., Goldszmid R. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 2006, 177(6):3515-3519.
8. Basso B. Modulation of immune response in experimental Chagas disease. World J. Exp. Med. 2013, 3(1):1-10.
9. Bayer-Santos E., Cunha-e-Silva N.L., Yoshida N., et al. Expression and cellular trafficking of GP82 and GP90 glycoproteins during Trypanosoma cruzi metacyclogenesis. Parasites Vectors 2013, 6:127.
10. Beg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002, 23(11):509-512.
11. Beschin A., Van Den Abbeele J., De Baetselier P., et al. African trypanosome control in the insect vector and mammalian host. Trends Parasitol. 2014, 30(11):538-547.
12. Boczkowski D., Nair S.K., Snyder D. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 1996, 184(2):465-472.
13. Brodskyn C., Patricio J., Oliveira R., et al. Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect. Immun. 2002, 70(7):3736-3743.
14. Burns K., Martinon F., Esslinger C. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 1998, 273(20):12203-12209.
15. Campos M.A., Almeida I.C., Takeuchi O. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 2001, 167(1):416-423.
16. Carlsen E.D., Jie Z., Liang Y., et al. Interactions between Neutrophils and Leishmania braziliensis amastigotes facilitate cell activation and parasite clearance. J. Innate Immun. 2015, 7(4):354-363.
17. Castillo-Acosta V.M., Ruiz-Pérez L.M., Van Damme E.J., et al. Exposure of Trypanosoma brucei to an N-acetylglucosamine-binding lectin induces VSG switching and glycosylation defects resulting in reduced infectivity. PLoS Neglected Trop. Dis. 2015, 9(3).
18. Cetron M.S., Basilio F.P., Moraes A.P. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection. Am. J. Trop. Med. Hyg. 1993, 49(3):370-382.
19. Chaudhary R., Amit A., Yadav A., et al. Immunomodulation in human dendritic cells leads to induction of interferon-gamma production by Leishmania donovani derived KMP-11 antigen via activation of NF-κB in Indian kala-azar patients. Biomed Res. Int. 2014, 2014, Article ID 947606, 12.
20. Chaussabel D., Pajak B., Vercruysse V., Bisseyé C., et al. Alteration of migration and maturation of dendritic cells and T-cell depletion in the course of experimental Trypanosoma cruzi infection. Lab. Investig. 2003, 83(9):1373-1382.
21. Chen H., Jiang Z. The essential adaptors of innate immune signaling. Protein Cell 2013, 4(1):27-39.
22. Cnops J., Magez S., De Trez C. Escape mechanisms of African trypanosomes: why trypanosomosis is keeping us awake. Parasitology 2015, 142(3):417-427.
23. Coller S.P., Mansfield J.M., Paulnock D.M. Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-gamma-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. J. Immunol. 2003, 171(3):1466-1472.
24. Contreras I., Estrada J.A., Guak H., et al. Impact of Leishmania mexicana infection on dendritic cell signaling and functions. PLoS Neglected Trop. Dis. 2014, 8(9).
25. Da Costa T.A., Silva M.V., Mendes M.T. Immunomodulation by Trypanosoma cruzi: toward understanding the association of dendritic cells with infecting TcI and TcII populations. J. Immunol. Res. 2014, 2014:12. article ID 962047.
26. Dagenais T.R., Freeman B.E., Demick K.P., et al. Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis. J. Immunol. 2009, 183(5):3344-3355.
27. Davis B.K., Wen H., Ting J.P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 2011, 29:707-735.
28. De Arruda Hinds L.B., Previato L.M., Previato J.O., et al. Modulation of B-lymphocyte and NK cell activities by glycoinositolphospholipid purified from Trypanosoma cruzi. Infect. Immun. 1999, 67(11):6177-6180.
29. De Nardo D. Toll-like receptors: activation, signalling and transcriptional modulation. Cytokine 2015, 74(2):181-189.
30. Drennan M.B., Stijlemans B., Van den Abbeele J., et al. The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J. Immunol. 2005, 175(4):2501-2509.
31. Eickhoff C.S., Giddings O.K., Yoshida N., et al. Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection. Memórias do Inst. Oswaldo Cruz 2010, 105(5):687-691.
32. Elliot S.L., Rodrigues J.O., Lorenzo M.G. Trypanosoma cruzi, etiological agent of Chagas disease, is virulent to its triatomine vector Rhodnius prolixus in a temperature-dependent manner. PLoS Neglected Trop. Dis. 2015, 9(3).
33. Falcão S.A., Weinkopff T., Hurrell B.P., et al. Exposure to Leishmania braziliensis triggers neutrophil activation and apoptosis. PLoS Neglected Trop. Dis. 2015, 9(3):e0003601.
34. Feijó D., Tibúrcio R., Ampuero M., et al. Dentritic cells and Leishmania infection: adding layers of complexity to a complex disease. J. Immunol. Reserch 2016, 2016(2016).
35. Ferguson M.A. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J. Cell Sci. 1999, 112:2799-2809.
36. Filardy A.A., Costa-da-Silva A.C., Koeller C.M., et al. Infection with Leishmania major induces a cellular stress response in macrophages. PLoS One 2014, 9(1).
37. Finberg E.K. Ironing out the role of Toll-like receptors. Blood 2015, 125(14):2183-2184.
38. Flores-García Y., Rosales-Encina J.L., Satoskar A.R., et al. IL-10-IFN-γ double producers CD4+ T cells are induced by immunization with an amastigote stage specific derived recombinant protein of Trypanosoma cruzi. Int. J. Biol. Sci. 2011, 7(8):1093-1100.
39. Flores-García Y., Rosales-Encina J.L., Rosales-García V.H., et al. CD4+ CD25+ FOXP3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model. Biomed Res. Int. 2013, 2013, Article ID 632436, 10.
40. Freire-de-Lima L., Fonseca L.M., Oeltmann T. The trans-sialidase, the major Trypanosoma cruzi virulence factor: three decades of studies. Glycobiology 2015, 1-8.
41. Freitas-Junior L.H., Briones M.R., Schenkman S. Two distinct groups of mucin-like genes are differentially expressed in the developmental stages of Trypanosoma cruzi. Mol. Biochem. Parasitol. 1998, 93(1):101-114.
42. Gabriel C., McMaster W.R., Girard D., et al. Leishmania donovani promastigotes evade the antimicrobial activity of neutrophil extracellular traps. J. Immunol. 2010, 185(7):4319-4327.
43. Garzón E., Holzmuller P., Bras-Gonçalves R., et al. The Trypanosoma brucei gambiense secretome impairs lipopolysaccharide-induced maturation, cytokine production, and allostimulatory capacity of dendritic cells. Infect. Immun. 2013, 81(9):3300-3308.
44. Gonçalves V.M., Matteucci K.C., Buzzo C.L. NLRP3 controls Trypanosoma cruzi infection through a caspase-1-dependent IL-1R-independent NO production. PLoS Neglected Trop. Dis. 2013, 7(10):e2469.
45. Gravina H.D., Antonelli L., Gazzinelli R.T., et al. Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi. PLoS One 2013, 8(5).
46. Gregory D.J., Olivier M. Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology 2005, 130.
47. Guimarães-Costa A.B., De Souza-Vieira T.S., Paletta-Silva R., et al. 3'-nucleotidase/nuclease activity allows Leishmania parasites to escape killing by neutrophil extracellular traps. Infect. Immun. 2014, 82(4):1732-1740.
48. Harris T.H., Cooney N.M., Mansfield J.M., et al. Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA. Infect. Immun. 2006, 74(8):4530-4537.
49. Harris T.H., Mansfield J.M., Paulnock D.M. CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes. Infect. Immun. 2007, 75(5):2366-2373.
50. Higgins M.K., Tkachenko O., Brown A., et al. Structure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunity. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(5):1905-1910.
51. Holzmuller P., Biron D.G., Courtois P., et al. Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics. Microbes Infect. 2008, 10(1):79-86.
52. Isnard A., Christian J.G., Kodiha M., et al. Impact of Leishmania infection on host macrophage nuclear physiology and nucleopore complex integrity. PLoS Pathog. 2015, 11(3). article e1004776.
53. Jarrossay D., Napolitani G., Colonna M., et al. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31(11):3388-3393.
54. Ji J., Sun J., Soong L. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect. Immun. 2003, 71(8):4278-4288.
55. Jo E.K., Kim J.K., Shin D.M., Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 2016, 13(2):148-159.
56. Junqueira C., Guerrero A.T., Galvão-Filho B., et al. Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine. PLoS One 2012, 7(5):e36245.
57. Kaliński P., Hilkens C.M., Wierenga E.A., et al. T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 1999, 20(12):561-567.
58. Kawamoto H., Minato N. Myeloid cells. Int. J. Biochem. Cell Biol. 2004, 36(8):1374-1379.
59. Kervic I., Cappel M.A., Keeling J.H. New world and old world Leishmania infections a practical review. Dermatol. Clin. 2015, 33:579-593.
60. Koga R., Hamano S., Kuwata H. TLR-dependent induction of IFN-β mediates host defense against Trypanosoma cruzi. J. Immunol. 2006, 177(10):7059-7066.
61. Krug A., Towarowski A., Britsch S., et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 2001, 31(10):3026-3037.
62. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30(1):16-34.
63. Laskay T., van Zandbergen G., Solbach W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology 2008, 213(3-4):183-191.
64. Leppert B.J., Mansfield J.M., Paulnock D.M. The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling. J. Immunol. 2007, 179(1):548-556.
65. Lima-Junior D.S., Costa D.L., Carregaro V., et al. Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania. Nat. Med. 2013, 19(7):909-915.
66. Liu D., Uzonna J.E. The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response. Front. Cell. Infect. Microbiol. 2012, (2). article 83.
67. Lopes M.F., Costa-da-Silva A.C., DosReis G.A. Innate immunity to Leishmania infection: within phagocytes. Mediat. Inflamm. 2014, 2014. article 754965.
68. Maddeb-Garnaoui A., Toumi A., Ghelis H., et al. Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively. Vaccine 2010, 28(7):1881-1886.
69. Marques C.S., Passero L.F., Vale-Gato I., et al. New insights into neutrophil and Leishmania infantum in vitro immune interactions, Comparative Immunology. Microbiol. Infect. Dis. 2015, 40:19-29.
70. Martins P.R., Nascimento R.D., Lopes J.G. Mast cells in the colon of Trypanosoma cruzi-infected patients: are they involved in the recruitment, survival and/or activation of eosinophils?. Parasitol. Res. 2015, 114(5):1847-1856.
71. McCulloch R., Field M.C. Quantitative sequencing confirms VSG diversity as central to immune evasion by Trypanosoma brucei. Trends Parasitol. 2015, 31(8):346-349.
72. Morán-Utrera Y., López-Monteon A., Rosales-Encina J.L., et al. Trypanosoma cruzi SSP4 amastigote protein induces expression of immunoregulatory and immunosuppressive molecules in peripheral blood mononuclear cells. J. Trop. Med. 2012, 2012, Article ID 829139, 10.
73. Moreira L.O., Zamboni D.S. NOD1 and NOD2 signaling in infection and inflammation. Front. Immunol. 2012, (3):328.
74. Namangala B., Baetselier P D.E., Beschin A. Quantitative differences in immune responses in mouse strains that differ in their susceptibility to Trypanosoma brucei brucei infection. J. Veterinary Med. Sci. 2009, 71(7):951-956.
75. Napetschnig J., Wu H. Molecular basis of NF-κB signaling. Annu. Rev. Biophys. 2013, 42:443-468.
76. Novais F.O., Carvalho L.P., Passos S., et al. Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology. J. Investig. Dermatol. 2015, 135(1):94-101.
77. Oliveira A.C., Peixoto J.R., Arruda L.B. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 2004, 173(9):5688-5696.
78. Paul J., Naskar K., Chowdhury S., et al. TLR4-mediated activation of MyD88 signaling induces protective immune response and IL-10 down-regulation in Leishmania donovani infection. Indian J. Biochem. Biophys. 2014, 51(6):531-541.
79. Petersen C.A., Krumholz K.A., Burleigh B.A. Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosomacruzi. Infect. Immun. 2005, 73(10):6974-6980.
80. Pletinckx K., Stijlemans B., Pavlovic V., et al. Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses. Eur. J. Immunol. 2011, 41(12):3479-3494.
81. Previato J.O., Wait R., Jones C., et al. Glycoinositolphospholipid from Trypanosoma cruzi: structure, biosynthesis and immunobiology. Adv. Parasitol. 2004, 56:1-41.
82. Qian Y., Commane M., Ninomiya-Tsuji J. IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFkappa B. J. Biol. Chem. 2001, 276(45):41661-41667.
83. Ramos-Ligonio A., López-Monteon A., Talamás-Rohana P., et al. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages. Parasite Immunol. 2004, 26(10):409-418.
84. Reis e Sousa C. Activation of dendritic cells: translating innate into adaptive immunity. Curr. Opin. Immunol. 2004, 16(1):21-25.
85. Riddell J., Gazit R., Garrison B.S. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 2014, 157(3):549-564.
86. Ropert C., Gazzinelli R.T. Signaling of immune system cells by glycosylphosphatidylinositol (GPI) anchor and related structures derived from parasitic protozoa. Curr. Opin. Microbiol. 2000, 3(4):395-403.
87. Rotureau B., Morales M.A., Bastin P., et al. The flagellum-mitogen-activated protein kinase connection in Trypanosomatids: a key sensory role in parasite signalling and development. Cell. Microbiol. 2009, 11(5):710-718.
88. Santori F.R., Paranhos-Bacalla G.S., Franco Da Silveira J., et al. A recombinant protein based on the Trypanosoma cruzi metacyclic trypomastigote 82-kilodalton antigen that induces and effective immune response to acute infection. Infect. Immun. 1996, 64(4):1093-1099.
89. Schnurr M., Then F., Galambos P., et al. Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J. Immunol. 2000, 165(8):4704-4709.
90. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140(6):821-832.
91. Sheel M., Engwerda C.R. The diverse roles of monocytes in inflammation caused by protozoan parasitic diseases. Trends Parasitol. 2012, 28(10):408-416.
92. Silva J.S., Vespa G.N., Cardoso M.A., et al. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 1995, 63(12):4862-4867.
93. Silva G.K., Gutierrez F.R., Guedes P.M. Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection. J. Immunol. 2010, 184(3):1148-1152.
94. Tabel H., Kaushik R.S., Uzonna J. Experimental African trypanosomiasis: differences in cytokine and nitric oxide production by macrophages from resistant and susceptible mice. Pathobiology 1999, 67(5-6):273-276.
95. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
96. Tarleton R.L. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 2007, 19(4):430-434.
97. Tatakihara V.L., Malvezi A.D., Panis C., et al. Nitric oxide-releasing indomethacin enhances susceptibility to Trypanosoma cruzi infection acting in the cell invasion and oxidative stress associated with anemia. Chemico-Biological Interact. 2015, 227:104-111.
98. Tavares N.M., Araújo-Santos T., Afonso L., et al. Undertanding the mechanisms controlling Leishmania amazonensis infection in vitro: the role LTB4 derived from human neutrophil. J. Infect. Dis. 2014, 210(4):656-666.
99. Teixeira A.R., Hecht M.M., Guimaro M.C. Pathogenesis of chagas' disease: parasite persistence and autoimmunity. Clin. Microbiol. Rev. 2011, 24(3):592-630.
100. Tiberti N., Lejon V., Ngoyi D.M., et al. Increased acute imune response during the meningo-encephalitic stage of Trypanosoma brucei rhodesiense sleeping sickness compared to Trypanosoma brucei gambiense. Transl. Proteom. 2015, 6:1-9.
101. Matzinger P. Tolerance, danger, and the extended Family. Annu. Rev. Immunol. 1994, 12:991-1045.
102. Ueno N., Wilson M.E. Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival. Trends Parasitol. 2012, 28(8):335-344.
103. Vázquez A., Ruiz-Rosado J.D., Terrazas L.I. Mouse macrophage galactose-type lectin (mMGL) is critical for host resistance against Trypanosoma cruzi infection. Int. J. Biol. Sci. 2014, 10(8):909-920.
104. Vespa G.N., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 1994, 62(11):5177-5182.
105. Vladimer G.I., Weng D., Paquette S.W. The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 2012, 37(3):588.
106. Wesche H., Henzel W.J., Shillinglaw W. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997, 7(6):837-847.
107. Yu X., Guo C., Fisher P.B., et al. Scavenger receptors: emerging roles in cancer biology and immunology. Adv. Cancer Res. 2015, 128:30.